References
- Barth R. F., Soloway A. H., Fairchild R. G., Brugger R. M. Boron neutron capture therapy for cancer. Realities and prospects. Cancer 1992; 70: 2995–3007
- Coderre J. A., Morris G. M. The radiation biology of boron neutron capture therapy. Radiat Res 1999; 151: 1–18
- Kortesniemi M., Seppala T., Auterinen I., Savolainen S. Enhanced blood boron concentration estimation for BPA‐F mediated BNCT. Appl Radiat Isot 2004; 61: 823–7
- Ryynänen P., Kangasmäki A., Hiismäki P., Coderre J., Diaz A., Kallio M., et al. Non‐linear model for the kinetics of 10B in blood after BPA‐fructose complex infusion. Phys Med Biol 2002; 47: 737–45
- Ryynänen P., Kortesniemi M., Coderre J., Diaz A., Hiismäki P., Savolainen S. Models for estimation of the 10B concentration after BPA‐fructose complex infusion in patients during epithermal neutron irradiation in BNCT. Int J Radiat Oncol Biol Phys 2000; 48: 1145–54
- Auterinen I., Hiismäki P., Kotiluoto P., Rosenberg R. J., Salmenhaara S., Seppälä T., . Metamorphosis of a 35 years old TRIGA reactor into a modern BNCT facility. Frontiers in neutron capture therapy, M. F Hawthorne, K Shelly, R. J Wiersema, et al. Plenum, New York 2001; 267–75
- Joensuu H., Kankaanranta L., Seppala T., Auterinen I., Kallio M., Kulvik M., et al. Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boron phenylalanine. J Neurooncol 2003; 62: 123–34
- Kouri M., Kankaanranta L., Seppala T., Tervo L., Rasilainen M., Minn H., et al. Undifferentiated sinonasal carcinoma may respond to single‐fraction boron neutron capture therapy. Radiother Oncol 2004; 72: 83–5
- NIH Clinical Trials. Available at: www.clinicaltrials.gov
- Kankaanranta L., Seppala T., Koivunoro H., Saarilahti K., Atula T., Collan J., et al. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 69: 475–82
- Laakso J., Kulvik M., Ruokonen I., Vahatalo J., Zilliacus R., Farkkila M., et al. Atomic emission method for total boron in blood during neutron‐capture therapy. Clin Chem 2001; 47: 1796–803
- Bauer W. F., Micca P. L., White B. M. A rapid method for the direct analysis of boron in whole blood by atomic emission spectroscopy. Advances in neutron capture therapy, A. H Soloway, R. F Barth, D. E Carpenter. Plenum Press, New York 1993
- Nichols T. L., Kabalka G. W., Miller L. F., Khan M. K., Smith G. T. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine‐18 labeled boronophenylalanine and positron emission tomography. Med Phys 2002; 29: 2351–8
- Imahori Y., Ueda S., Ohmori Y., Sakae K., Kusuki T., Kobayashi T., et al. Positron emission tomography‐based boron neutron capture therapy using boronophenylalanine for high‐grade gliomas: part II. Clin Cancer Res 1998; 4: 1833–41
- Zuo C. S., Prasad P. V., Busse P., Tang L., Zamenhof R. G. Proton nuclear magnetic resonance measurement of p‐boronophenylalanine (BPA): a therapeutic agent for boron neutron capture. Med Phys 1999; 26: 1230–6
- Heikkinen S., Kangasmäki A., Timonen M., Kankaanranta L., Häkkinen A. M., Lundbom N., et al. 1H MRS of a boron neutron capture therapy 10B‐carrier, BPA‐F: phantom studies at 1.5 and 3.0 T. Phys Med Bio 2003; 48: 1027–39
- Timonen M., Kangasmäki A., Savolainen S., Heikkinen S. 1H MRS phantom studies of BNCT 10B‐carrier, BPA‐F using STEAM and PRESS MRS sequences: detection limit and quantification Spectrosc. Int J 2004; 18: 133–42
- Timonen M., Collan J., Kankaanranta L., Lundbom N., Collan J., Kangasmäki A., et al. 1H MRS studies in the Finnish Boron Neutron Capture Therapy project: detection of 10B‐carrier, L‐p‐boronophenylalanine‐fructose. EJR 2005; 56: 154–9
- Munck af Rosenschold P. M., Verbakel W. F., Ceberg C. P., Stecher‐Rasmussen F., Persson B. R. Toward clinical application of prompt gamma spectroscopy for in vivo monitoring of boron uptake in boron neutron capture therapy. Med Phys 2001; 28: 787–95